VEGFA and cancer: With recent studies demonstrating the therapeutic benefit of ICIs either as a single agent or in combination with other ICIs or nephrotoxic cancer agents (e.g., platinum or vascular endothelial growth factor inhibitors), ICI therapies are being used more frequently.